The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

Author

Summary, in English

Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans.

Topic

  • Cardiac and Cardiovascular Systems
  • Endocrinology and Diabetes

Keywords

  • Breast Neoplasms: blood
  • Breast Neoplasms: mortality
  • Cardiovascular Diseases: blood
  • Cardiovascular Diseases: mortality
  • Diabetes Mellitus: blood
  • Diabetes Mellitus: mortality
  • Neurotensin: blood
  • Protein Precursors: blood
  • Sweden: epidemiology

Status

Published

Research group

  • Cardiovascular Research - Hypertension
  • Genomics, Diabetes and Endocrinology
  • Surgery
  • Cardiovascular Research - Epidemiology
  • Internal Medicine - Epidemiology
  • Diabetes - Cardiovascular Disease

ISBN/ISSN/Other

  • ISSN: 1538-3598